English
Home > Products > Agomelatine intermediate

China Agomelatine intermediate Factory

Together with the "Client-Oriented" enterprise philosophy, a arduous good quality control technique, sophisticated producing equipment and a sturdy R&D staff, we generally offer superior quality merchandise, superb solutions and aggressive rates for Agomelatine intermediate,CAS NO 138113-08-3,138113-08-3,Agomelatine advance intermediate,7-Methoxy-1-naphthylacetonitrile, For anyone who is fascinated in any items, be sure to truly feel totally free to speak to us for further more details or be sure to deliver us email immediately, we will reply you in 24 hrs as well as the most effective quotation will probably be provided.
Agomelatine intermediate, Welcome any of your inquiries and concerns for our products. We look forward to establishing a long-term business relationship with you in the near future. Contact us today. We are the first business partner to suit your needs!

Related Products

Hot Products

  • 4-Amino-3-fluorophenol

    4-Amino-3-fluorophenol

    Product Name:4-Amino-3-fluorophenol
    Molecular Formula:C6H6FNO
    Molecular Weight:127.12
    CAS Registry Number:399-95-1
  • Diisopropylammonium dichloroacetate

    Diisopropylammonium dichloroacetate

    Product Name:Diisopropylammonium dichloroacetate
    Molecular Formula:C8H17Cl2NO2
    Molecular Weight;230.13208
    CAS Registry Number;660-27-5
  • Bleomycin sulfate

    Bleomycin sulfate

    Product Name:Bleomycin sulfate
    Molecular Formula:C110H168N34O46S7
    Molecular Weight;2927.17
    CAS Registry Number;9041-93-4
  • 3-Dimethylaminopropyl chloride hydrochloride

    3-Dimethylaminopropyl chloride hydrochloride

    Product Name:3-Dimethylaminopropyl chloride hydrochloride
    Molecular Formula:C5H13Cl2N
    Molecular Weight:158.07
    CAS Registry Number:5407-04-5
  • Amoxicillin

    Amoxicillin

    Product Name:Amoxicillin
    Molecular Formula:C16H19N3O5S
    Molecular Weight;365.4
    CAS Registry Number;26787-78-0
  • Metformin HCL

    Metformin HCL

    Product Name:Metformin HCL
    Molecular Formula:C4H11N5
    Molecular Weight;165.62
    CAS Registry Number;15537-72-1
  • Related Blog
  • Reviews

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept